Top

Reactions Weekly

Published in:

01-01-2024 | Tigecycline | Case report

Levetiracetam/tigecycline

Rhabdomyolysis and elevated creatine kinase

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Chatterjee S, et al. Suspected Tigecycline and Levetiracetam induced raised Creatine Kinase (CK) and Rhabdomyolysis. Journal of the Indian Medical Association 121: 45-47, No. 11, Nov 2023

Title: Levetiracetam/tigecycline
Rhabdomyolysis and elevated creatine kinase
Publication date: 01-01-2024
Publisher: Springer International Publishing
Keywords: Tigecycline
Levetiracetam
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-52280-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Levetiracetam/tigecycline

Rhabdomyolysis and elevated creatine kinase

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Hydrocortisone/Itraconazole/Prednisolone

Atezolizumab/bevacizumab

Clindamycin/linezolid/sulfamethoxazole

Tozinameran

Multiple drugs

Antiarrhythmics